Answers are grounded in this paper and cite their sources.
Background Chronic lower respiratory disease (CLRD) and type 2 diabetes mellitus (T2DM) are among the leading causes of death in the United States (US). CLRD and T2DM frequently coexist and share overlapping risk factors, including obesity, a sedentary lifestyle, systemic inflammation, and socioeconomic disadvantage, which can worsen outcomes. Methods Serial cross-sectional mortality analysis using death certificates sourced from the CDC WONDER database for the years 1999–2024 was conducted. Deaths among adults aged ≥ 25 years with both CLRD (ICD-10 codes J40–J47) and T2DM (ICD-10 codes E11.0–E11.9) listed anywhere on the death certificate were included. Age-adjusted mortality rates (AAMRs) per 100,000 persons were standardized to the 2000 US standard population. Annual percentage changes (APCs) and average annual percentage changes (AAPCs) were estimated using Joinpoint regression, with stratification by sex, race/ethnicity, census region, age group, and urbanization. Results From 1999 to 2024, of 326,655 deaths, AAMR rose from 2.65 (95% CI 2.57–2.73) to 7.92 (95% CI 7.82–8.02) per 100,000 (AAPC 4.14%; 95% CI 2.88–5.42; P < 0.001). AAMRs rose in women (2.09 to 6.54; AAPC 4.32%; P < 0.001) and men (3.60 to 9.75; AAPC 3.79%; P < 0.001). By age, the steepest rise was in adults aged 45–64 years (1.03 to 3.49; AAPC 4.85%; 95% CI 3.21-6.50; P < 0.001), followed by those aged ≥65 years (11.71 to 34.13; AAPC 4.04%; P < 0.001); the rise in adults aged 25–44 years was not significant (AAPC 3.47%, 2000–2024; P = 0.141). Rates rose in all racial and ethnic groups, most steeply in non-Hispanic Black adults (2.19 to 8.00; AAPC 4.56%; 95% CI 2.21-6.98; P < 0.001). Among census regions, the West had the steepest rise (2.31 to 9.55; AAPC 5.84%; 95% CI 4.45-7.25; P < 0.001), and non-metropolitan areas had higher AAMRs than metropolitan areas (AAPC 5.72% vs. 5.23%; both P < 0.001; 1999-2020). California had the highest death count; the highest AAMRs were in West Virginia in 1999–2020 (11.46) and Wyoming in 2021–2024 (19.16); and decedent's home was the most common place of death (33.2% in 1999-2020; 42.4% in 2021-2024). Conclusions Mortality involving both CLRD and type 2 DM rose substantially; rates were highest among older adults, men, and non-metropolitan residents. These findings support the evaluation of coordinated pulmonary and metabolic care in these groups; however, causal inference is limited.
No takes yet. Share an insight, caveat, or question.
Kumari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: